article thumbnail

Xencor In Licensing Deal With Merck

socalTECH

Monrovia-based Xencor announced today that it is in a technology license and option agreement with biotech giant Merck. Xencor said that the deal provides Merck with access to one of its patents for therapeutic monoclonal antibodies. xencor merck licensing patent therapeutic monoclonal antibodies lifescience' READ MORE>>.

Patents 138